Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Daniel Willis
Benchmark founder Malcolm Pye will step down as chief executive later this year.
US company ImmuCell has seen its share price drop to its lowest level since 2017.
Danish biotechnology company Novozymes has appointed Lars Green to the role of executive vice president and corporate finance officer.
US feed additives firm BV Science has increased its presence in Europe after opening a new distribution center in Budapest, Hungary.
Elanco has seen its share price decline following its second-quarter results.
US pet health specialist Better Choice is working on clinical studies on the potential of cannabidiol (CBD) products to reduce anxiety in dogs.